Accuracy of conventional cytology: Results from a multicentre screening study in India

Journal of Medical Screening

Volumn 11, Issue 2, 2004, Pages 77-84

  Sankaranarayanan, R ^a   Thara, S ^b   Sharma, A ^c   Roy, C ^d   Shastri, S ^e   Mahe C ^a   Muwonge, R ^a   Fontaniere B ^f  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b REGIONAL CANCER CENTRE   (India)

^c Bhagwan Mahaveer Cancer Hospital and Research Centre   (India)

^d CHITTARANJAN NATIONAL CANCER INSTITUTE   (India)

^e TATA MEMORIAL HOSPITAL   (India)

^f CENTRE LÉON BÉRARD   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACCURACY; ADULT; AGED; ARTICLE; CANCER RESEARCH; CANCER SCREENING; COLPOSCOPY; CONTROLLED STUDY; CYTOLOGY; FEMALE; HISTOLOGY; HUMAN; INDIA; MAJOR CLINICAL STUDY; MEDICAL ASSESSMENT; MEDICAL RESEARCH; QUESTIONNAIRE; SCREENING TEST; SQUAMOUS CELL; SQUAMOUS CELL CARCINOMA; STANDARDIZATION;

ADULT; AGE FACTORS; AGED; CARCINOMA IN SITU; CERVICAL INTRAEPITHELIAL NEOPLASIA; CYTOLOGY; FEMALE; HUMANS; INDIA; MASS SCREENING; MIDDLE AGED; QUESTIONNAIRES; SENSITIVITY AND SPECIFICITY; UTERINE CERVICAL NEOPLASMS;

EID: 3042517059     PISSN: 09691413     EISSN: None     Source Type: Journal    
DOI: 10.1258/096914104774061056     Document Type: Article

References (29)

1. Parkin DM, Bray FI, Devassa SS. Cancer burden in the year 2000. The global picture. Eur J Cancer 2001;37:S4-S66.
2. Sankaranarayanan R, Budhuk A, Rajkumar R. Effective screening programs for cervical cancer in low- and middle-income developing countries. Bull World Health Organization 2001;79:954-62.
3. Robles SC, White F, Peruga A. Trends in cervical cancer mortality in the Americas. Bull Pan Am Health Organ 1996;30:290-301.
4. Sellors J, Sankaranarayanan R. Colpscopy and treatment of cervical intraepithelial neoplasia: A beginners manual. IARC non-serial publication, 2003.
5. Solomon D. The 1988 Bethesda system for reporting cervical/vaginal cytologic diagnoses. Developed and approved at the National Cancer Institute Workshop, Bethesda, Maryland, USA, December, 12-13. Acta Cytological 1989;33:567-74.
6. Kurman RJ, Malkasian GD Jr., Sedits A, Solomon D. From Papanicolaou to Bethesda: the rationale for a new cervical cytologic classification. Obstet Gynecol 1991;77:779-82.
7. Santos Silva I. (ed.) Cancer Epidemiology, Principles and Methods. International Agency for Research on Cancer, Lyon, 1999.
8. Hakama M, Miller AB, Day NE. (Eds) Screening for cancer of the uterine cervix. IARC Scientific Publication No.76. Lyon, 1986.
9. Anderson GH, Boyes DA, Benedet JL, et al. Organisation and results of the cervical cytology screening programme in British Columbia, 1955-85. BMJ 1988;296:975-78.
10. Laara E, Day NE, Hakama M. Trends in mortality from cervical cancer in the Nordic countries: association with organised screening programmes. Lancet 1987;1:1247-49.
11. Lazcano-Ponce EC, Buiatti E, Najera-Aguilar P, et al. Evaluation model of the Mexican national program for early detection and proposals for a new approach. Cancer Causes and Control 1998;9:241-51.
12. Londhe M, George SS, Seshadri L. Detection of CIN by naked eye visualization after application of acetic acid. Indian J Cancer 1997;34:88-91.
13. Sankaranarayanan R, Wesley R, Somanathan T, et al. Visual inspection of the uterine cervix after the application of acetic acid in the detection of cervical carcinoma and its precursors. Cancer 1998;83:2150-56.
14. Sankaranarayanan R, Shyamalakumari B, Wesley R, et al. Visual inspection with acetic acid in the early detection of cervical cancer and precancers. Int J Cancer 1999;80:161-63.
15. Denny L, Kuhn L, Pollack A et al. Evaluation of alternative methods of cervical cancer screening in resource poor settings. Cancer 2000;89:826-3.
16. Denny L, Kuhn L, Pollack A, Wright TC Jr. Direct visual inspection for cervical cancer screening: an analysis of factors influencing test performance. Cancer 2002;94:1699-707.
17. University of Zimbabwe/JHPIEGO Cervical Cancer Project. Visual inspection with acetic acid for cervical cancer screening: test qualities in a primary-care setting. Lancet 1999;353:869-73.
18. Salmeron J, Lazcano-Ponce E, Lorincz A, et al. Comparison of HPV-based assays with Papanicolaou smears for cervical cancer screening in Morelos State, Mexico. Cancer Causes Control 2003;14:505-12.
19. Choi BCK. Sensitivity and specificity of a single diagnostic test in the presence of work up bias. J Clin Epidemiol 1992;45:581-86.
20. US Preventive Services Task Force. Screening for cervical cancer. Am Fam Physician 1990;41:853-57.
21. Eddy DM. Screening for cervical cancer. Ann Int Med 1990;113:214-26.
22. Shield PW, Daunter B, Wright RG. The Pap smear revisited. Aust NZ J Obst Gynecol 1987;27:269-79.
23. Wilkinson EJ. Pap smears and screening for cervical neoplasia. Clin Obstet Gynecol 1990;33:817-825.
24. Fahey MT, Irwig L, Macaskill P. Meta-analysis of Pap test Accuracy. Am J Epidemiol 1995;141:680-89.
25. Mitchell MF, Schottenfeld D, Tortolera-Luna G, et al. Colposcopy for the diagnosis of squamous intraepithelial lesions: a meta-analysis. Obstet Gynecol 1998;91:626-31.
26. Nanda K, McCrory DC, Myers ER, et al. Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: A systematic review. Ann Intern Med 2000;132:810-19.
27. Sasieni P, Adams J, Cuzick J. Benefit of cervical screening at different ages: evidence from the UK audit of screening histories. Br J Cancer 2003;89:88-93.
28. Sankaranarayanan R, Basu P, Wesley R, et al. Visual screening for cervical neoplasia: Results from an IARC multicentre study in India and Africa. Int J Cancer 2004 (in press).
29. Lazcano-Ponce EC, Alonco de Ruiz P, Lopez-Carrillo L, et al. Validity and reproducibility of cytologic diagnosis in a sample of cervical cancer screening centres in Mexico. Acta Cytol 1997;41:277-84.